ORKA – oruka therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Oruka Therapeutics, Inc. (NASDAQ: ORKA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $45.00 price target on the stock.
Oruka Therapeutics Announces First Participants Dosed in Phase 1 Trial of ORKA-001, its Novel Half-life Extended Anti-IL-23p19 Antibody [Yahoo! Finance]
Oruka Therapeutics Announces First Participants Dosed in Phase 1 Trial of ORKA-001, its Novel Half-life Extended Anti-IL-23p19 Antibody
Oruka Therapeutics to be Added to the Nasdaq Biotechnology Index (NBI) [Yahoo! Finance]
Oruka Therapeutics to be Added to the Nasdaq Biotechnology Index (NBI)
Form 8-K Oruka Therapeutics, Inc. For: Dec 17
Form EFFECT Oruka Therapeutics, Inc.
Form SC 13D/A Oruka Therapeutics, Inc. Filed by: Fairmount Funds Management LLC
Form 4 Oruka Therapeutics, Inc. For: Nov 19 Filed by: Kiselak Tomas
Form 8-K Oruka Therapeutics, Inc. For: Nov 14
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.